Page 815 - Veterinary Immunology, 10th Edition
P. 815

Leptospira grippotyphosa (K)       <1 yr               N/A
  VetBooks.ir   Leptospira pomona (K)              <1 yr               N/A
                                                                       <75
                                                   <1 yr
                Leptospira icterohaemorrhagiae (K)
                                                   1 yr
                                                                       <75
                Borrelia burgdorferi (K)
                Borrelia burgdorferi OspA (R)
                Giardia lamblia (K)                1 yr                <75
                                                   <1 yr
                                                                       N/A
               From Paul MA, Appel M, Barrett R, et al: Report of the American Animal Hospital
               Association (AAHA) Canine Vaccine Task Force: executive summary and 2003 canine
               vaccine guidelines and recommendations, J Am Anim Hosp Assoc 39:119-131, 2003.
                  Annual revaccination was once the rule for most animal vaccines
               since this approach is administratively simple and has the
               advantage of ensuring that an animal is regularly seen by a

               veterinarian. It is clear, however, that vaccines such as those against
               canine distemper or feline herpesvirus induce protective immunity
               that can last for many years, and that annual revaccination using

               these vaccines is inappropriate. A growing body of evidence now
               indicates that most modified live viral (MLV) vaccines induce
               lifelong sterile immunity in dogs and cats. In contrast, immunity to
               bacteria is of much shorter duration and often may prevent disease
               but not infection. Old dogs and cats rarely die from vaccine-

               preventable disease, especially if they have been vaccinated as
               adults. Young animals, in contrast, may die from such diseases,
               especially if not vaccinated or if vaccinated prematurely. A

               veterinarian should always assess the relative risks and benefits to
               an animal in determining the timing of any vaccination. It is
               therefore good practice to use serum antibody assays such as rapid
               test enzyme-linked immunosorbent assay (ELISA) kits, if available,
               to provide guidance on revaccination intervals. Persistent antibody

               titers determine whether an animal requires additional protection.
               These tests not only identify those animals that have responded to
               vaccination, they can determine if an animal is a nonresponder.

               They can determine if an animal that previously suffered from an
               adverse event really requires revaccination. They can determine
               whether an animal with an undocumented vaccine history needs to
               be vaccinated and with which vaccines. They can determine which
               animals in a shelter undergoing a disease outbreak are susceptible

               and so require vaccination. They can also determine whether
               revaccination is really necessary at 3 years. It should be pointed out,
               however, that animals with low or undetectable serum antibody

               levels may still be protected as a result of persistence of memory B
               and T cells capable of responding rapidly to reinfection. “Blind”




                                                         815
   810   811   812   813   814   815   816   817   818   819   820